Table 4

 Significant demographic, clinical, and social risk factors associated with drug resistance in all patients (multivariate analysis)*

ParameterAny resistanceIsoniazidRifampicinMDR TB (all cases)MDR TB (new cases)
p valueOR(95% CI)p valueOR(95% CI)p valueOR(95% CI)p valueOR(95% CI)p valueOR(95% CI)
*Parameters are for all TB patients unless indicated for prisoner or civilian subgroups alone.
Sex (males v females) in civilians0.0363.0 (1.1 to 8.3)
Previous TB treatment for >4 weeks0.0381.7 (1.0 to 2.8)0.0421.7 (1.1 to 2.8)
    Civilians0.0014.0 (2.0 to 8.1)0.0017.4 (1.9 to 29.1)
    Prisoners0.0533.7 (1.1 to 14.2)
Previous treatment at prison dispensary in civilians0.0524.3 (0.9 to 18.3)
Currently on TB treatment0.0022.5 (1.4 to 5.0)0.0292.2 (1.1 to 4.6)0.0142.8 (1.2 to 6.5)
    Civilians0.0043.7 (1.5 to 9.1)0.0342.2 (1.1 to 4.7)0.0264.2 (1.2 to 14.7)
Currently on long term treatment−1.10.0513.4 (1.0 to 11.2)
Fibrocavitary TB0.045.0 (1.1 to 10.0)0.0192.2 (1.1 to 4.4)0.0013.5 (1.8 to 6.7)
    Prisoners0.0053.4 (1.4 to 8.2)0.0233.2 (1.2 to 8.7)0.0482.6 (1.1 to 6.9)
Accompanying COPD0.0422.1 (1.0 to 4.3)0.0023.5 (1.6 to 7.7)
HIV infection0.0090.3 (0.1 to 0.8)
    Prisoners0.0060.3 (0.1 to 0.7)
History of imprisonment0.0212.1 (1.1 to 4.1)
    Civilians0.0413.4 (1.1 to 11.1)
Smoking0.0213.3 (1.2 to 9.2)
Recreational drug use0.033.0 (1.1 to 7.9)